<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd"><ep-patent-document id="EP0552264A1" file="EP91919268NWA1.xml" lang="en" doc-number="0552264" date-publ="19930728" kind="A1" country="EP" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSE........................................................................</B001EP><B003EP>*</B003EP><B007EP>EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)</B007EP></eptags></B000><B100><B110>0552264</B110><B130>A1</B130><B140><date>19930728</date></B140><B190>EP</B190></B100><B200><B210>91919268.0</B210><B220><date>19911009</date></B220><B240><B241><date>19930325</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>19900022117</B310><B320><date>19901011</date></B320><B330><ctry>GB</ctry></B330></B300><B400><B405><date>19930728</date><bnum>199330</bnum></B405><B430><date>19930728</date><bnum>199330</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  31/   395            A I                    </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  31/    55            A I                    </text></classification-ipcr><classification-ipcr sequence="3"><text>A61P  43/    00            A I                    </text></classification-ipcr><classification-ipcr sequence="4"><text>C07D 243/    08            A I                    </text></classification-ipcr><classification-ipcr sequence="5"><text>C07D 245/    02            A I                    </text></classification-ipcr><classification-ipcr sequence="6"><text>C07D 247/    00            A I                    </text></classification-ipcr></B510EP><B540><B541>en</B541><B542>N-(2-ALKYL-3-MERCAPTOGLUTARYL)-AMINO-DIAZA CYCLOALKANONE DERIVATIVES AND THEIR USE AS COLLAGENASE INHIBITORS</B542><B541>fr</B541><B542>DERIVES DE N-(2-ALKYLE-3-MERCAPTOGLUTARYLE)-AMINO-DIAZA CYCLOALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE COLLAGENASE</B542><B541>de</B541><B542>N-(2-ALKYL-3-MERCAPTOGLUTARYL)-AMINO-DIAZACYCLOALKANONDERIVATE UND IHRE VERWENDUNG ALS COLLAGENASEINHIBITOREN</B542></B540></B500><B700><B710><B711><snm>BEECHAM GROUP plc</snm><adr><str>Four New Horizons Court, Harlequin Avenue</str><city>Brentford Middlesex TW8 9EP</city><ctry>GB</ctry></adr></B711></B710><B720><B721><snm>MARKWELL, Roger, Edward SmithKline Beecham Pharm.</snm><adr><str>Coldhabour Road The Pinnacles</str><city>Harlow Essex CM19 5AD</city><ctry>GB</ctry></adr></B721><B721><snm>WARD, Robert, William SmithKline Beecham Pharma.</snm><adr><str>Coldhabour Road The Pinnacles</str><city>Harlow Essex CM19 5AD</city><ctry>GB</ctry></adr></B721><B721><snm>RAHMAN, Shahzad, Sharooq SmithKline Beecham Phar.</snm><adr><str>Coldhabour Road The Pinnacles</str><city>Harlow Essex CM19 5AD</city><ctry>GB</ctry></adr></B721></B720><B740><B741><snm>Giddings, Peter John, Dr., et al</snm><adr><str>SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road</str><city>Brentford, Middlesex TW8 9BD</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>NL</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>GB1991001749</anum></dnum><date>19911009</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO1992006966</pnum></dnum><date>19920430</date><bnum>199210</bnum></B871></B870></B800></SDOBI></ep-patent-document>